An Exploratory, Multi-cohort Phase II Study of Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
An Exploratory, Multi-cohort Phase II Study of combination therapy of AK112 with chemotherapy and/or olaparib in platinum-sensitive ovarian cancer(PSOC)
Epistemonikos ID: 2da5f9ff0351adb40dafb800aaeb22e9cbf16760
First added on: Dec 01, 2024